In terms of Rule 48 of Public Procurement Rules, 2004 Grievance Redressal Committee (GRC) is notified for the subject procurement and notification copy is available on the procuring agency’s website and on Authority’s website at (www.ppra.org.pk).
LINAR, LARKANA (Pakistan Atomic Energy Commission), Director / Head of Establishment
LINAR Cancer Hospital Shaikh Zaid Women Hospital, Larkana
+92-333-753566
linarlarkana@paec.gov.pk
Sections of Prequalifica¬tion Documents
The following specific data for the Prequalification of Applicants shall complement, supplement, or amend the provisions in the Instructions to Applicants (ITA). Whenever there is a conflict, the provisions herein shall prevail over those in ITA.
PDS Clause No
ITA No
Amendments of, and Supplements to, Clauses in the Instructions to Applicants
PDS Clause No 1
ITA No 1.1
Identification Number of the Invitation for Prequalification: P44135
The Procuring Agency is: LINAR, LARKANA (Pakistan Atomic Energy Commission)
List of Contracts:
See section items and Lots
PDS Clause No 2
ITA No 2.1
The name of Procuring Agency is: LINAR, LARKANA (Pakistan Atomic Energy Commission)
The name of Project / Procurement is: Tender Notice No. 02/2026 - Purchase of anti cancer medicines out of PBM Funds
PDS Clause No 3
ITA No 4.2
Maximum number of members in a Joint Venture (JV): Nil
PDS Clause No 4
ITA No 4.5
A list of debarred firms and individuals is available on PPRA website:https://ppra.gov.pk
PDS Clause No 5
ITA No 7.1
For clarification, the Applicant shall seek clarifications through: EPADS v2.0
PDS Clause No 6
ITA No 7.1 & 8.2
Information related to Prequalification shall be published on: EPADS v2.0
PDS Clause No 7
ITA No 7.2
Pre-Application Meeting: Clarification Date: Friday, June 5, 2026
PDS Clause No 8
ITA No 10.1
This Prequalification Document has been issued in the language: English
PDS Clause No 9
ITA No 11.1(d)
Additional documents to be submitted through EPADS v2.0:
No
PDS Clause No 10
ITA No 14.2
Source for determining exchange rates: Not Applicable
PDS Clause No 11
ITA No 16.1
Deadline for Application Submission:
Day: Saturday
Date: Saturday, June 20, 2026
Time: 10:00 AM
PDS Clause No 12
ITA No 17.1
Opening of Applications shall be conducted through: EPADS v2.0
Day: Saturday
Date: Saturday, June 20, 2026
Time: 10:30 AM
Virtual participation link: https://vendors.epads.gov.pk/
PDS Clause No 13
ITA No 21.1
Margin of Domestic Preference: Not Applicable
(Applicable only if authorized in Procurement Plan)
PDS Clause No 14
ITA No 29.1
Prequalification-related complaints / grievances shall be submitted in writing through: EPADS v2.0
A complaint may challenge:
| Bidder's Type | Required Registration |
|---|---|
|
Sole Proprietorship Partnership Firm Company (Private Limited) Company (Public Limited) Company (Limited by Guarantee) |
FBR (NTN) FBR (GSTN) Punjab (PRA) SECP DRAP |
Quality Based Selection (QBS)
| Technical Marks | 70 | |
|---|---|---|
| Passing Marks | 50 | |
| Technical Evaluation Criteria | ||
| Product Registration Category A 1) US FDA 2) EMA(Western Europe) 3) MHRA UK 4) TGA Australia 5) PHARMAC, New Zeeland 6) PMDA Japan 7) Swiss-Medic Switzerland 8) Health Canada 9) HAS Singapore (Qualitative)(Doc Required) | 30 | |
| Product Registration Category B 1) EMA (Central or Eastern Europe) 2) ANVIS Brazil 3) CDSCO India 4) NPCB Malaysia 5) FDA South Korea 6) MOH Egypt 7) MOH Turkey 8) FDA China 9) ANMAT Argentina 10) DRA Pakistan 11) Or any other Authority not mentioned in Category A. (Qualitative)(Doc Required) | 20 | |
| Country of Manufacturing Category A 1)US 2) Western Europe 3)UK 4)Australia 5) New Zeeland 6)Japan 7)Switzerland 8)Canada 9)Singapore (Qualitative)(Doc Required) | 20 | |
| Financial Marks | 30 | |
| Financial Evaluation Criteria | ||
| Financial Weightage Formula Total Marks.30 Financial Marks F = ( A_) x 30 B A is the price of lowest quoted drug. B is the price of product under consideration | − | 30 |